Jump to Content Jump to Main Navigation

EPR21-034: Epidemiology of Diffuse Large B Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) Patients by Line of Therapy in the United States (US) and Europe (EU)

Authors: Wenzhen Ge PhD¹, Jon E. Arnason MD², Ruben G.W. Quek PhD¹, Katie Keeven MA³, Knar Nersesyan MA, MS³, and Gena Kanas MPH, PhD³

View More View Less

¹ Regeneron Pharmaceuticals Inc., Tarrytown, NY
| ² Beth Israel Deaconess Medical Center, Boston, MA
| ³ Kantar - Health Division, New York, NY

Volume/Issue:: Volume 19: Issue 3.5

Online Publication Date:: 17 Mar 2021

DOI:: https://doi.org/10.6004/jnccn.2020.7742

Restricted access

All currencies in US Dollar

Corresponding Author: Gena Kanas, MPH, PhD

Print
Save
Cite
Email this content

Share Link

Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:

https://jnccn.org/abstract/journals/jnccn/19/3.5/article-pEPR21-034.xml
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully

Top

Copyright:: Copyright © 2021 by the National Comprehensive Cancer Network 2021

Article Category:: Abstract

Print Publication Date:: 20 Mar 2021

Online Publication Date:: 17 Mar 2021

Get Permissions

Similar articles in Google Scholar

	All Time	Past Year	Past 30 Days
Abstract Views	0	0	0
Full Text Views	548	548	212
PDF Downloads	626	626	218
EPUB Downloads	0	0	0